CHEMICAL COMPOUNDS TARGETING THE EYE AND USE THEREOF IN THE TREATMENT OF EYE DISEASES

The invention relates to chemical compounds C that are derivatives of norbixine and have tropism for the eye, and are intended to be used in the treatment of eye diseases in mammals, in particular in the context of altering the retinal pigment epithelium and more particularly in the context of age-r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VEILLET, Stanislas, DILDA, Pierre, LATIL, Mathilde, CAMELO, Serge, DINAN, Laurence, SAHEL, José-Alain, BALDUCCI, Christine, MONTEIRO, Elodie, GUIBOUT, Louis, FONTAINE, Valérie, LAFONT, René
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to chemical compounds C that are derivatives of norbixine and have tropism for the eye, and are intended to be used in the treatment of eye diseases in mammals, in particular in the context of altering the retinal pigment epithelium and more particularly in the context of age-related macular degeneration (AMD) and Stargardt's disease. L'invention concerne des composés chimiques C dérivés de la norbixine et présentant un tropisme pour l'œil, destinés à être utilisés dans le traitement de maladies oculaires chez le mammifère, notamment dans le contexte d'une altération de l'épithélium pigmentaire rétinien et plus particulièrement dans le cadre de la dégénérescence maculaire liée à l'âge (DMLA) et la maladie de Stargardt.